logo

For the Inventor, By the Inventor

Ikeda, Japan

Shigehisa Taketomi

This inventor holds 21 USPTO granted patents and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1977-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigehisa Taketomi. Retrieved from https://idiyas.com/inventor/shigehisa-taketomi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 90.5


Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 153(Granted Patents)


Location History:

  • Osaka, JA (1977)
  • Suita, JA (1978)
  • Ikeda, JP (1994 - 2002)
  • Osaka, JP (1995 - 2003)

Company Filing History:

goldMedal21 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1977-2003

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Composition
Bisphosphonic Acid
Osteogenic
Transmucosal
Polypeptides
Quinoline
Quinazoline
Cell Differentiation
Parathyroid Hormone
Benzopyran
Therapeutic Composition
Bone Resorption Inhibitor
21 patents (USPTO):Explore Patents
1. 6632807 - (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide (2003-10-14),
2. 6489351 - Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentation induction factor action (2002-12-03),
3. 6391905 - Condensed 4,5,6,7-tetrahydrobenzo[C]thiopenes as enhancer for cell differentiation induction factor action (2002-05-21),
4. 6346521 - Optically active 2R, 4S benzothiepin isomer (2002-02-12),
5. 6242471 - Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentiation induction factor action (2001-06-05),
6. 6066658 - Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell (2000-05-23),
7. 6025467 - Parathyroid hormone derivatives and their use (2000-02-15),
8. 5910492 - Osteogenic promoting pharmaceutical composition (1999-06-08),
9. 5852039 - Pharmaceutical composition containing quinoline or quinazoline (1998-12-22),
10. 5741784 - Benzopyran derivatives and their use (1998-04-21),
11. 5725852 - Transmucosal therapeutic composition (1998-03-10),
12. 5719157 - Pharmaceutical composition containing quinoline or quinazoline (1998-02-17),
13. 5716944 - Phosphonic acid compounds, their production and use (1998-02-10),
14. 5580863 - Benzopyran derivatives and their use (1996-12-03),
15. 5512552 - Bisphosphonic acid derivatives, and pharmaceutical use (1996-04-30),

Title: Innovations and Contributions of Shigehisa Taketomi

Introduction: Shigehisa Taketomi, based in Ikeda, Japan, is a prominent inventor with a remarkable contribution to the field of pharmaceuticals. With a portfolio of 21 patents, Taketomi has played a pivotal role in advancing chemical compounds and their applications in medicine.

Latest Patents: Among his latest innovations, Taketomi has developed a compound titled (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5-tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide. Additionally, he has worked on the creation of condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes, which act as enhancers for cell differentiation induction factor action, showcasing his focus on improving therapeutic efficacy.

Career Highlights: Currently employed at Takeda Chemical Industries, Inc., Shigehisa Taketomi continues to innovate in the pharmaceutical sector. His extensive work on chemical compounds demonstrates his expertise and commitment to enhancing drug formulations and therapeutic strategies.

Collaborations: Taketomi collaborates with notable coworkers, including Takashi Sohda and Tsuneo Oda. Together, they contribute to ongoing research and development efforts, fostering a dynamic and collaborative environment that drives innovation.

Conclusion: Shigehisa Taketomi's contributions to the field of chemistry and pharmaceuticals underline the importance of innovation in developing new medical solutions. His various patents not only reveal his dedication to research but also highlight the collaborative efforts that propel advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…